Apply Now
Deadline: October 4, 2026

South Africa Market Discovery: Life Sciences and HealthTech

Validate your expansion into South Africa's Life Sciences and HealthTech markets and assess your
product-market fit.

South Africa | October 26 - December 4, 2026

For German Life Sciences and HealthTech startups exploring South Africa as a strategic growth market

Into this Program

South Africa has the most developed health system on the continent: academic hospitals, national private hospital groups, country wide pathology networks and internationally recognized clinical research capability, concentrated in a single market. For German Life Sciences and HealthTech companies it is both a commercial market in its own right and a realistic entry point into Sub-Saharan Africa.

It is also a market that punishes assumptions. Healthcare runs on two tiers: a private sector funded by medical schemes, and a public system that procures at national scale.

Both are reachable, and each demands a different go-to-market, a different pricing logic and a different evidence base. Add SAHPRA registration timelines, tender procurement rules and distributor-led sales, and the cost of guessing rises quickly.

South Africa Market Discovery is a high-touch program that tests your specific market hypotheses through curated access to the institutions that decide whether a health technology gets adopted.

This is not a pitch tour.
This is a decision program.

What You Gain

Structured Market Validation

Evidence-based testing of your South Africa market hypotheses, specific to your segment and your buyer.

Curated Access

High-quality 1:1 introduction to hospitals, laboratories, payers, regulators, universities and corporates.

Regulatory and Procurement Clarity

How SAHPRA registration, tender procurement and medical scheme reimbursement actually work in practice.

Decision Clarity

A clear Enter, Delay or Deprioritize outcome, backed by real market signals.

Founder-Level Support

Experienced mentors who understand both European and South African healthcare operating realities.

Post-Program Continuity

Structured follow-up after the on-site week to turn promising conversations into concrete next steps.

“We are not running a trip. Before you land, we learn your product, your buyer and the question you actually need answered. Then we do the difficult part, which is getting you in front of the people in South Africa who can answer it. And if the honest answer turns out to be that this is not your market, that is a result worth having. It saves you a year.”

- Niklas Linss, Project Lead Africa, German Accelerator

Solutions We Are Looking For

PRIORITY

Diagnostics and Laboratory Technology

Molecular and rapid diagnostics, genomics and sequencing, point of care testing, oncology and infectious disease, laboratory workflow, automation and informatics

PRIORITY

Digital Health and Clinical AI

Clinical decision support, imaging and diagnostic AI, telehealth and remote care delivery, remote patient monitoring, hospital and clinical workflow software, patient engagement

PRIORITY

Medical Devices and MedTech

Hospital, surgical, imaging and monitoring equipment, consumables, and devices designed for resource-varied care settings

Clinical Research and Trial Enablement

Clinical trial technologies, site enablement, regulatory and quality systems

Research Tools and Bio Manufacturing

Instrumentation for universities, research institutes and CROs, bioprocessing, advanced materials for medical use, manufacturing technology

Public Health and Surveillance Technology

Disease surveillance, antimicrobial resistance, infection prevention, public health data and intelligence

Who You Will Meet

Curated access means named institutions, matched to your hypotheses. In South Africa that means:

Private hospital groups and clinic networks

National pathology and laboratory networks

Medical schemes and private payers

Academic hospitals, universities and clinical research sites

SAHPRA and public health institutions

Distributors, corporate partners and investors

Every meeting is matched company by company. This is not a group tour.

Your Concrete Takeaways:

Market hypothesis and decision brief.

Validated or falsified use cases for South Africa.

Documented customer, clinical and partner signals.

Regulatory, procurement and reimbursement reality check.

Clear next-step roadmap covering go-to market, partnerships and pilots.

Is This Program Right for You?

German-based startup, Pre-Seed to Series A.

Life Sciences or HealthTech focus.

First traction in DACH or wider European markets.

Seeking evidence-based validation, not visibility.

Looking for implementation, clinical or distribution partners.

Ready to commit founder time to the on-site week in November.

Program Details

Location:

Hybrid: Online, plus Johannesburg and Cape Town, South Africa

Program Dates:

October 26 - December 4, 2026

Cohort Size

7 Startups

In-country Dates:

November 16 - 20, 2026

Format:

1:1 Interaction, B2B matches, Mentor support

Application Deadline:

October 4, 2026

Cost:

500€ per Startup

Test

Meet all Startup Stories

"I would say one of the things that really impressed me was the high profile of the experts that they German Accelerator introduced us to."

Read Story
Trinh Le-Fiedler
CEO & Co-Founder

"When it comes to choosing a startup accelerator for international expansion, Kellermann is clear: “In my opinion, I highly recommend German Accelerator,” he said."

Read Story
Julian Kellermann
Managing Director

"A ten-minute in-person meeting saved a lot of paperwork. Being physically present in Asia made all the difference."

Read Story
Otto Klemke
Co-Founder and CEO

"With our market plans to expand into the U.S., the mentors immensely helped us by giving deep insights on how to improve our pitch, our market focus and segmentation, our approach, and our communication and branding."

Read Story
Dr. Arne Kruse
Co-Founder

"It’s all about meeting the right people, so the German Accelerator network was most relevant to our success,” said Pentenrieder. “I’m excited to continue collaborating with that network."

Read Story
Martin Pentenrieder
Co-Founder
Testimonials

What Previous Program Participants Say

Dr. Michael Schoepf
Business Development Manager

"This one week actually saved us the work of one entire year. It was very helpful to get a feeling on the market potentials, and to get really good contacts."

Venios

Frequently Asked Questions

Questions Before You Apply?

Talk to the people running the program, in Germany and in South Africa.

Niklas Linss

Project Lead Africa

Contact

Ntokozo Ncongwane

South Africa Market Development Lead

Contact
01

Submit Your Application

Submit your pitch deck along with answers to key questions about your business, including your vision, market-fit, and current growth stage. This information will help assess your company’s potential for success and eligibility for the German Accelerator program.

02

Selection Process

Our team will carefully evaluate your application, reviewing all provided materials including your pitch deck and company details. If your startup is selected and meets the eligibility criteria, you will be notified of the next steps.

03

Time to Roll Up Your Sleeves

Participate in the program and start working on the basics for international expansion via 1:1 mentor sessions, workshops, and fireside chats with our expert mentors.

04

Ready, Set, Go!

With clear feedback on your market readiness and concrete next steps from the program, you’ll know exactly how to move forward with your expansion. If you're ready to take the next step, check out German Accelerator's Market Access or explore more markets with Market Discovery.

Contact

Do you have any other Questions